Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dimebon

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Living with dementia

misplacing items1 - sleep1 - genetic evidence1 - astro-gliosis1 - alcoholic encephalopathy10 - dementia of the alzheimer type1 - dementia135 - deep-brain stimulation3 - tuberculosis1 - beta amyloid3 - caregiving2 - urinary incontinence2 - peripheral arterial disease1 - dementias first signs1 - alcohol abuse4 - arnold pick1 - motor development1 - vitamin b-11 - common form of dementia1 - treatment of alzheimer's disease1 - alzheimer's society2 - igf-11 - blood pressure6 - huntington's disease8 - risk for cognitive decline1 - korsakoff syndrome3 - rates of dementia1 - obstructive lung disease1 - dementia progression1 - causes of dementia1 -